ADHD trials recruiting in Alabama

All ADHD trials nationally

Cities in Alabama

Recruiting trials in Alabama

• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
  NCT04781140 · Phase: Phase 4 · Ages: 48 Months to 69 Months · Sex: All (male and female) · Alabama: Saraland
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
  NCT07717879 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · Alabama: Dothan
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
  NCT07717892 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Alabama: Dothan
• Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
  NCT05776056 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Alabama: Birmingham, Tuscaloosa
• Mindfulness Intervention for College Students With ADHD
  NCT06076967 · Phase: Not applicable (e.g. observational or device study) · Ages: 17 Years to 25 Years · Sex: All (male and female) · Alabama: Tuscaloosa